Regenerative cell therapy using purified Mesenchymal Stem Cells
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT06521736
Brain-computer Interface Commercial Readiness
Phase: N/A
Role: Collaborator
Start: Sep 13, 2024
Completion: Apr 30, 2026
Loading map...